OKUROnKure Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of OnKure Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OKUR본 종목 | $116M#7 | — | 0.7x#1 | — | — | -13.0%#9 | — | -34.6%#5 | — | — | — | — |
| UNCY | $133M#2 | — | 2.5x#6 | 196.8x#4 | -29.0%#5 | 27.7%#5 | -4372.9%#5 | -49.8%#7 | — | — | — | — |
| APMD | $1.1B#1 | — | — | — | — | — | — | — | — | — | — | — |
| HURA | $129M#3 | — | 7.0x#11 | — | — | -34.8%#10 | — | -167.6%#11 | -0.1%#1 | — | -17.9%#2 | — |
| BMEA | $126M#4 | — | 10.4x#13 | — | — | 55.4%#4 | — | -509.2%#13 | — | — | -14.3%#1 | — |
| MNOV | $123M#5 | — | 3.3x#7 | 300.4x#5 | — | 8.6%#7 | -3242.5%#3 | 32.2%#1 | — | — | — | — |
| INO | $119M#6 | — | 27.2x#14 | 1819.7x#6 | -70.0%#6 | 20.6%#6 | -132871.3%#6 | -1944.6%#14 | -243.9%#2 | — | — | — |
| AARD | $113M#8 | — | 1.5x#3 | — | — | -179.7%#13 | — | -77.0%#8 | — | — | -49.8%#4 | — |
| PMN | $112M#9 | — | 2.3x#4 | — | — | -1529.3%#14 | — | -80.4%#9 | — | — | — | — |
| MIST | $111M#10 | — | 6.1x#9 | — | — | -51.9%#12 | — | -0.3%#2 | — | — | — | — |
| GNLX | $107M#11 | — | 6.6x#10 | 13347.4x#7 | 0.0%#4 | -7.6%#8 | -415175.0%#7 | -199.5%#12 | -424.2%#3 | — | -42.6%#3 | — |
| COYA | $106M#12 | — | 2.4x#5 | 13.3x#2 | 123.6%#1 | -42.6%#11 | -283.9%#2 | -49.0%#6 | — | — | — | — |
| CPIX | $104M#13 | — | 6.0x#8 | 2.3x#1 | 17.6%#3 | 56.2%#3 | -6.3%#1 | -16.3%#4 | — | — | — | — |
| PLYX | $101M#14 | — | 9.3x#12 | — | — | 70.4%#2 | — | -82.1%#10 | — | — | — | — |
| RLYB | $89M#15 | 3.4x#1 | 0.9x#2 | 104.0x#3 | 34.9%#2 | 84.5%#1 | -3853.6%#4 | -9.5%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice